Weill Cornell Medicine has been awarded a five-year, $4.2 million grant by the National Cancer Institute to investigate the molecular mechanisms by which immune cells interact with Epstein-Barr virus to cause lymphoma, particularly in people living with HIV.
Black and Hispanic patients were more likely than white patients to develop a wide array of lasting symptoms and conditions after a COVID-19 diagnosis, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
A new screening tool identified roughly half of primary care patients with chronic obstructive pulmonary disorder who could benefit from available treatments, according to a nationwide study.
An experimental contraceptive drug candidate developed by Weill Cornell Medicine investigators temporarily stops sperm in their tracks and prevents pregnancies in preclinical models.
Two new grants from the Leukemia & Lymphoma Society will support Weill Cornell Medicine’s pathbreaking research on the origins of lymphomas and on treatments that exploit these cancers’ biological vulnerabilities.
Surgery that removes only a portion of one of the five lobes that comprise a lung is as effective as the traditional surgery that removes an entire lobe for certain patients with early-stage lung cancer, a new study has found.
New York Lt. Gov. Antonio Delgado engaged with students and faculty on topics ranging from biological engineering to nutrition to 4-H programs during his first tour of the Ithaca campus on Feb. 2.
The $3.5 million grant will go toward the improvement of screening and preventive treatment of cervical cancer for women living with HIV in low-resource countries.
